在 glomerular C3 / C5转化酶的现场评估表明IgA脏病中正在进行的补充激活
Augustin Obrecht1, Marie-Sophie Meuleman2,3, Jérôme Olagne1,4
1Department of Nephrology, Dialysis and Transplantation, Strasbourg University Hospitals, Strasbourg, France.
概括
这项研究表明,检测活检中的补体转化酶可以识别IgA病 (IgAN) 中正在进行的炎症. 这种方法有助于确定那些可能受益于IGAN补充向治疗的患者.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 补充系统生物学 补充系统生物学
背景情况:
- 补体系统在IgA病 (IgAN) 进展中发挥作用,呈现治疗点.
- 目前用于评估IgAN补充激活的方法在区分活跃和过去的炎症方面缺乏精度.
研究的目的:
- 为了评估在IgA脏病 (IgAN) 脏活检中补体转化酶的 in situ检测.
- 为了将补充通路激活与疾病严重程度和临床结果相关联.
- 确定潜在的生物标志物,以指导IGAN中的补充向疗法.
主要方法:
- 在53名Igan患者的活检中评估了补体沉积 (C4d,C5b-9,C3b/iC3b,C1q).
- 在33次活检中使用在位近距离结合试验 (Duolink®) 来检测经典/乳素 (C4b2b) 和替代 (C3bBb) 途径转化酶.
- 量化了转化酶信号,并将它们与MEST-C分数,C5b-9沉积和性存活率相关联.
主要成果:
- 替代途径 (C3bBb) 和经典/乳素途径 (C4b2b) 转化酶在大多数C3c阳性Igan患者中被检测到 (分别为60.6%和66.7%).
- 在39.4%的患者中观察到两种转化酶的存在;双阴性患者表现出更好的存期 (P=0.0387).
- C3bBb转化酶强度与C5b-9沉积相关 (P=0.0011) 并且在MEST-C分数E1和S1.1的患者中更高.
结论:
- 在现场转化酶检测显示,87.9%的C3c阳性Igan患者正在进行补充激活.
- 替代途径的激活与特定的病变 (E1,S1),C5b-9沉积和较差的结局有关.
- 这种技术可能会改善患者选择IGAN补充抑制疗法.
相关概念视频
Complement System
9.4K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
9.4K
Acute Kidney Injury III: Clinical Manifestations
754
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
754
Nephrotic Syndrome II : Assessment and Medical Management
177
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
177


